Levofloxacin
Levofloxacin comes in 54 pill versions in our database, in 3 strengths, from 29 manufacturers. Check the imprint to tell them apart.
Levofloxacin pill images
250 mg 17 pills
- LEVAQUIN 250 Levofloxacin 250 mg Pink, oval, 15 mm Used for bronchitis and urinary tract infections (UTIs)
- RDY 279 Levofloxacin 250 mg White, capsule, 14 mm Used for bronchitis and urinary tract infections (UTIs)
- TEVA 7291 Levofloxacin 250 mg Pink, oval, 14 mm Used for bronchitis and urinary tract infections (UTIs)
- W 544 Levofloxacin 250 mg Pink, capsule, 14 mm Used for bronchitis and urinary tract infections (UTIs)
- ML 62 Levofloxacin 250 mg Pink, capsule, 15 mm Used for bronchitis and urinary tract infections (UTIs)
- 13 T Levofloxacin 250 mg Pink, capsule, 15 mm Used for bronchitis and urinary tract infections (UTIs)
- I 25 Levofloxacin 250 mg Pink, capsule, 13 mm Used for bronchitis and urinary tract infections (UTIs)
- SZ 985 Levofloxacin 250 mg Brown, octagon, 14 mm Used for bronchitis and urinary tract infections (UTIs)
- 250 C282 Levofloxacin 250 mg Brown, oval, 13 mm Used for bronchitis and urinary tract infections (UTIs)
- T4 Levofloxacin 250 mg Pink, capsule, 15 mm Used for bronchitis and urinary tract infections (UTIs)
- ZC55 Levofloxacin 250 mg White, capsule, 15 mm Used for bronchitis and urinary tract infections (UTIs)
- L021 Levofloxacin 250 mg Pink, rectangle, 15 mm Used for bronchitis and urinary tract infections (UTIs)
- CE 150 Levofloxacin 250 mg White, oval, 13 mm Used for bronchitis and urinary tract infections (UTIs)
- JP Levofloxacin Hemihydrate 250 mg Pink, capsule Used for bronchitis and urinary tract infections (UTIs)
- No picture yet DIN 02284707 Levofloxacin Hemihydrate 250 mg Apo-Levofloxacin, Tablet, sold in Canada Used for bronchitis and urinary tract infections (UTIs)
- No picture yet DIN 02298635 Levofloxacin Hemihydrate 250 mg Sandoz Levofloxacin, Tablet, sold in Canada Used for bronchitis and urinary tract infections (UTIs)
- No picture yet DIN 02315424 Levofloxacin Hemihydrate 250 mg Teva-Levofloxacin, Tablet, sold in Canada Used for bronchitis and urinary tract infections (UTIs)
500 mg 20 pills
- LEVAQUIN 500 Levofloxacin 500 mg Orange, oval, 18 mm Used for bronchitis and urinary tract infections (UTIs)
- TEVA 7292 Levofloxacin 500 mg Orange, oval, 17 mm Used for bronchitis and urinary tract infections (UTIs)
- RDY 280 Levofloxacin 500 mg Orange, capsule, 18 mm Used for bronchitis and urinary tract infections (UTIs)
- W 545 Levofloxacin 500 mg Orange, capsule, 18 mm Used for bronchitis and urinary tract infections (UTIs)
- 83 Levofloxacin 500 mg Red, capsule, 16 mm Used for bronchitis and urinary tract infections (UTIs)
- 12 T Levofloxacin 500 mg Orange, capsule, 19 mm Used for bronchitis and urinary tract infections (UTIs)
- ML 63 Levofloxacin 500 mg Orange, oval, 19 mm Used for bronchitis and urinary tract infections (UTIs)
- ZC56 Levofloxacin 500 mg White, capsule, 19 mm Used for bronchitis and urinary tract infections (UTIs)
- ML 63 Levofloxacin 500 mg Orange, capsule, 19 mm Used for bronchitis and urinary tract infections (UTIs)
- SZ 986 Levofloxacin 500 mg Orange, octagon, 18 mm Used for bronchitis and urinary tract infections (UTIs)
- 500 C289 Levofloxacin 500 mg Yellow, oval, 17 mm Used for bronchitis and urinary tract infections (UTIs)
- T7 Levofloxacin 500 mg Orange, capsule, 19 mm Used for bronchitis and urinary tract infections (UTIs)
- I 26 Levofloxacin 500 mg Orange, capsule, 18 mm Used for bronchitis and urinary tract infections (UTIs)
- L022 Levofloxacin 500 mg Pink, rectangle, 18 mm Used for bronchitis and urinary tract infections (UTIs)
- CE 151 Levofloxacin 500 mg White, oval, 17 mm Used for bronchitis and urinary tract infections (UTIs)
- APO LFX 500 Levofloxacin Hemihydrate 500 mg Orange, capsule Used for bronchitis and urinary tract infections (UTIs)
- JP Levofloxacin Hemihydrate 500 mg Orange, capsule Used for bronchitis and urinary tract infections (UTIs)
- No picture yet DIN 02298643 Levofloxacin Hemihydrate 500 mg Sandoz Levofloxacin, Tablet, sold in Canada Used for bronchitis and urinary tract infections (UTIs)
- No picture yet DIN 02315432 Levofloxacin Hemihydrate 500 mg Teva-Levofloxacin, Tablet, sold in Canada Used for bronchitis and urinary tract infections (UTIs)
- No picture yet DIN 02415879 Levofloxacin Hemihydrate 500 mg Pro-Levofloxacin, Tablet, sold in Canada Used for bronchitis and urinary tract infections (UTIs)
750 mg 17 pills
- LEVAQUIN 750 Levofloxacin 750 mg White, oval, 20 mm Used for bronchitis and urinary tract infections (UTIs)
- RDY 281 Levofloxacin 750 mg Yellow, capsule, 19 mm Used for bronchitis and urinary tract infections (UTIs)
- TEVA 7293 Levofloxacin 750 mg White, oval, 20 mm Used for bronchitis and urinary tract infections (UTIs)
- W 547 Levofloxacin 750 mg White, capsule, 22 mm Used for bronchitis and urinary tract infections (UTIs)
- ML 64 Levofloxacin 750 mg White, capsule, 22 mm Used for bronchitis and urinary tract infections (UTIs)
- 750 C287 Levofloxacin 750 mg White, oval, 20 mm Used for bronchitis and urinary tract infections (UTIs)
- ZC57 Levofloxacin 750 mg White, capsule, 22 mm Used for bronchitis and urinary tract infections (UTIs)
- SZ 987 Levofloxacin 750 mg Yellow, octagon, 20 mm Used for bronchitis and urinary tract infections (UTIs)
- I 18 Levofloxacin 750 mg White, capsule, 21 mm Used for bronchitis and urinary tract infections (UTIs)
- T5 Levofloxacin 750 mg White, capsule, 22 mm Used for bronchitis and urinary tract infections (UTIs)
- 11 T Levofloxacin 750 mg White, capsule, 22 mm Used for bronchitis and urinary tract infections (UTIs)
- L023 Levofloxacin 750 mg White, capsule, 22 mm Used for bronchitis and urinary tract infections (UTIs)
- CE 152 Levofloxacin 750 mg White, oval, 19 mm Used for bronchitis and urinary tract infections (UTIs)
- JP Levofloxacin Hemihydrate 750 mg White, capsule Used for bronchitis and urinary tract infections (UTIs)
- No picture yet DIN 02298651 Levofloxacin Hemihydrate 750 mg Sandoz Levofloxacin, Tablet, sold in Canada Used for bronchitis and urinary tract infections (UTIs)
- No picture yet DIN 02315440 Levofloxacin Hemihydrate 750 mg Teva-Levofloxacin, Tablet, sold in Canada Used for bronchitis and urinary tract infections (UTIs)
- No picture yet DIN 02325942 Levofloxacin Hemihydrate 750 mg Apo-Levofloxacin, Tablet, sold in Canada Used for bronchitis and urinary tract infections (UTIs)
What is Levofloxacin used for?
Levofloxacin is used for bronchitis, urinary tract infections (UTIs), pneumonia and skin infections.
- Medicine type
- Antibiotic (fluoroquinolone)
Official uses from the US prescribing label
Nosocomial Pneumonia
Levofloxacin tablets are indicated in adult patients for the treatment of nosocomial pneumonia due to methicillin-susceptible Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae,or Streptococcus pneumoniae. Adjunctive therapy should be used as clinically indicated. Where Pseudomonas aeruginosais a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended.
Community-Acquired Pneumonia: 7 to 14 day Treatment Regimen
Levofloxacin tablets are indicated in adult patients for the treatment of community-acquired pneumonia due to methicillin-susceptible Staphylococcus aureus, Streptococcus pneumoniae(including multi-drug-resistant Streptococcus pneumoniae[MDRSP]), Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydophila pneumoniae, Legionella pneumophila,or Mycoplasma pneumoniae.
MDRSP isolates are isolates resistant to two or more of the following antibacterials: penicillin (MIC ≥2 mcg/mL), 2 ndgeneration cephalosporins, e.g., cefuroxime, macrolides, tetracyclines and trimethoprim/sulfamethoxazole.
Community-Acquired Pneumonia: 5-day Treatment Regimen
Levofloxacin tablets are indicated in adult patients for the treatment of community-acquired pneumonia due to Streptococcus pneumoniae(excluding multi-drug-resistant isolates [MDRSP]), Haemophilus influenzae, Haemophilus parainfluenzae, Mycoplasma pneumoniae,or Chlamydophila pneumoniae.
Complicated Skin and Skin Structure Infections
Levofloxacin tablets are indicated in adult patients for the treatment of complicated skin and skin structure infections due to methicillin-susceptible Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes,or Proteus mirabilis.
Uncomplicated Skin and Skin Structure Infections
Levofloxacin tablets are indicated in adult patients for the treatment of uncomplicated skin and skin structure infections (mild to moderate) including abscesses, cellulitis, furuncles, impetigo, pyoderma, wound infections, due to methicillin-susceptible Staphylococcus aureus,or Streptococcus pyogenes.
Chronic Bacterial Prostatitis
Levofloxacin tablets are indicated in adult patients for the treatment of chronic bacterial prostatitis due to Escherichia coli, Enterococcus faecalis,or methicillin-susceptible Staphylococcus epidermidis.
Inhalational Anthrax (Post-Exposure)
Levofloxacin tablets are indicated for inhalational anthrax (post-exposure) to reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracisin adults and pediatric patients, 6 months of age and older. The effectiveness of levofloxacin tablets is based on plasma concentrations achieved in humans, a surrogate endpoint reasonably likely to predict clinical benefit. Levofloxacin tablets have not been tested in humans for the post-exposure prevention of inhalation anthrax. The safety of levofloxacin tablets in adults for durations of therapy beyond 28 days or in pediatric patients for durations of therapy beyond 14 days has not been studied. Prolonged levofloxacin tablets therapy should only be used when the benefit outweighs the risk.
Plague
Levofloxacin tablets are indicated for treatment of plague, including pneumonic and septicemic plague, due to Yersinia pestis( Y. pestis) and prophylaxis for plague in adults and pediatric patients, 6 months of age and older.
Efficacy studies of levofloxacin tablets could not be conducted in humans with plague for ethical and feasibility reasons. Therefore, approval of this indication was based on an efficacy study conducted in animals.
Complicated Urinary Tract Infections: 5-day Treatment Regimen
Levofloxacin tablets are indicated in adult patients for the treatment of complicated urinary tract infections due to Escherichia coli, Klebsiella pneumoniae,or Proteus mirabilis.
Complicated Urinary Tract Infections: 10-day Treatment Regimen
Levofloxacin tablets are indicated in adult patients for the treatment of complicated urinary tract infections (mild to moderate) due to Enterococcus faecalis, Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis,or Pseudomonas aeruginosa.
Acute Pyelonephritis: 5 or 10-day Treatment Regimen
Levofloxacin tablets are indicated in adult patients for the treatment of acute pyelonephritis caused by Escherichia coli, including cases with concurrent bacteremia.
Uncomplicated Urinary Tract Infections
Levofloxacin tablets are indicated in adult patients for the treatment of uncomplicated urinary tract infections (mild to moderate) due to Escherichia coli, Klebsiella pneumoniae,or Staphylococcus saprophyticus.
Because fluoroquinolones, including levofloxacin tablets, have been associated with serious adverse reactions and for some patients uncomplicated urinary tract infection is self-limiting, reserve levofloxacin tablets for treatment of uncomplicated urinary tract infections in patients who have no alternative treatment options.
Acute Bacterial Exacerbation of Chronic Bronchitis
Levofloxacin tablets are indicated in adult patients for the treatment of acute bacterial exacerbation of chronic bronchitis (ABECB) due to methicillin-susceptible Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae,or Moraxella catarrhalis.
From the FDA-approved label on DailyMed (published Sep 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.